Home ETF List About

Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for BEAM

Stock NameBeam Therapeutics Inc
TickerBEAM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS07373V1052

Show aggregate BEAM holdings

News associated with BEAM

Beam Therapeutics (NASDAQ:BEAM) Earns “Buy” Rating from HC Wainwright
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued on Monday,Benzinga reports. They currently have a $80.00 price target on the stock. HC Wainwright’s target price points to a potential upside of 249.19% from the company’s previous close. A number […] - 2025-09-17 02:46:44
Beam Therapeutics (NASDAQ:BEAM) Downgraded by Wall Street Zen to “Sell”
Wall Street Zen lowered shares of Beam Therapeutics (NASDAQ:BEAM – Free Report) from a hold rating to a sell rating in a report published on Sunday. BEAM has been the topic of several other reports. Barclays lowered their price objective on shares of Beam Therapeutics from $25.00 to $21.00 and set an “equal weight” rating […] - 2025-09-15 04:42:44
Beam Therapeutics (NASDAQ:BEAM) Stock Rating Upgraded by Wall Street Zen
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued on Saturday. Several other equities analysts have also commented on BEAM. Cantor Fitzgerald raised Beam Therapeutics to a “strong-buy” rating in a report on Monday, July […] - 2025-09-08 03:02:55
Beam Therapeutics Inc. (NASDAQ:BEAM) Receives Consensus Recommendation of “Buy” from Brokerages
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned a consensus rating of “Buy” from the fourteen research firms that are covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating, nine have issued a buy rating and three have assigned a strong buy rating to the […] - 2025-08-07 02:38:51
Victory Capital Management Inc. Has $207,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Victory Capital Management Inc. boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 18.0% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 10,612 shares of the company’s stock after purchasing an additional 1,618 shares during the period. Victory Capital […] - 2025-08-04 05:14:52
Bank of New York Mellon Corp Boosts Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Bank of New York Mellon Corp increased its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 14.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 318,026 shares of the company’s stock after buying an additional […] - 2025-07-24 04:27:08
Arizona State Retirement System Boosts Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Arizona State Retirement System raised its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, Holdings Channel reports. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam Therapeutics were worth $499,000 as of […] - 2025-07-22 07:42:58
Arizona State Retirement System Has $499,000 Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Arizona State Retirement System boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 25.6% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 25,534 shares of the company’s stock after purchasing an additional 5,197 shares during the period. Arizona State Retirement System’s holdings in Beam […] - 2025-07-22 06:57:02
D.A. Davidson & CO. Has $1.38 Million Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
D.A. Davidson & CO. boosted its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 37.8% in the 1st quarter, HoldingsChannel reports. The firm owned 70,857 shares of the company’s stock after acquiring an additional 19,448 shares during the period. D.A. Davidson & CO.’s holdings in Beam Therapeutics were worth $1,384,000 as of its […] - 2025-07-09 05:53:15
QRG Capital Management Inc. Sells 870 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
QRG Capital Management Inc. cut its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 16,635 shares of the company’s stock after selling 870 shares during the period. QRG […] - 2025-06-24 04:46:59
Beam Therapeutics Inc. (NASDAQ:BEAM) Given Average Recommendation of “Buy” by Analysts
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) has been assigned an average recommendation of “Buy” from the fifteen analysts that are covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and two have assigned a strong buy rating to the […] - 2025-06-23 04:48:53
Implied ESGV Analyst Target Price: $116
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:27:28
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by Northern Trust Corp
Northern Trust Corp boosted its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 7.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 740,506 shares of the company’s stock after acquiring an additional 49,415 shares during the period. Northern Trust […] - 2025-05-14 05:54:50
Stifel Financial Corp Acquires 2,976 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
Stifel Financial Corp boosted its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 27.8% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 13,662 shares of the company’s stock after acquiring an additional 2,976 shares during the quarter. Stifel Financial Corp’s […] - 2025-05-14 04:56:47
Beam Therapeutics (NASDAQ:BEAM) Trading Down 6.8% Following Weak Earnings
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) shares traded down 6.8% during mid-day trading on Tuesday following a dissappointing earnings announcement. The company traded as low as $18.37 and last traded at $18.47. 326,775 shares traded hands during mid-day trading, a decline of 83% from the average session volume of 1,947,803 shares. The stock […] - 2025-05-08 02:42:51
Dimensional Fund Advisors LP Has $38.16 Million Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Dimensional Fund Advisors LP boosted its stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 24.0% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,538,398 shares of the company’s stock after purchasing an additional 298,067 shares during the period. Dimensional Fund Advisors […] - 2025-05-05 05:20:53
Implied VBK Analyst Target Price: $326
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-04-24 08:03:06
Beam Therapeutics Inc. (NASDAQ:BEAM) Stake Lifted by Sterling Capital Management LLC
Sterling Capital Management LLC raised its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 816.0% during the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,409 shares of the company’s stock after buying an additional 2,146 shares during the quarter. Sterling Capital Management LLC’s holdings in Beam […] - 2025-04-24 06:31:07
Beam Therapeutics Target of Unusually Large Options Trading (NASDAQ:BEAM)
Beam Therapeutics Inc. (NASDAQ:BEAM – Get Free Report) was the recipient of some unusual options trading activity on Tuesday. Investors acquired 10,060 put options on the company. This is an increase of approximately 1,089% compared to the typical daily volume of 846 put options. Beam Therapeutics Stock Up 3.9 % Beam Therapeutics stock opened at […] - 2025-04-24 02:30:49
Beam Therapeutics Inc. (NASDAQ:BEAM) Shares Purchased by LPL Financial LLC
LPL Financial LLC grew its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 5.6% during the fourth quarter, Holdings Channel reports. The firm owned 27,698 shares of the company’s stock after acquiring an additional 1,462 shares during the quarter. LPL Financial LLC’s holdings in Beam Therapeutics were worth $687,000 as of […] - 2025-04-23 04:22:56
Federated Hermes Inc. Decreases Position in Beam Therapeutics Inc. (NASDAQ:BEAM)
Federated Hermes Inc. decreased its holdings in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 20.8% in the 4th quarter, HoldingsChannel.com reports. The fund owned 29,709 shares of the company’s stock after selling 7,792 shares during the quarter. Federated Hermes Inc.’s holdings in Beam Therapeutics were worth $737,000 as of its most recent SEC filing. […] - 2025-04-17 05:16:55
Beam Therapeutics Inc. (NASDAQ:BEAM) Holdings Decreased by Russell Investments Group Ltd.
Russell Investments Group Ltd. cut its position in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 6.2% during the 4th quarter, HoldingsChannel.com reports. The firm owned 176,181 shares of the company’s stock after selling 11,664 shares during the period. Russell Investments Group Ltd.’s holdings in Beam Therapeutics were worth $4,369,000 as of its […] - 2025-04-16 05:06:53
Geode Capital Management LLC Trims Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
Geode Capital Management LLC cut its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 0.2% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,804,374 shares of the company’s stock after selling 3,309 shares during the quarter. Geode Capital Management […] - 2025-04-15 05:01:01
JPMorgan Chase & Co. Sells 125,567 Shares of Beam Therapeutics Inc. (NASDAQ:BEAM)
JPMorgan Chase & Co. lowered its holdings in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 19.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 513,671 shares of the company’s stock after selling 125,567 shares during the period. […] - 2025-04-14 04:36:51
Alliancebernstein L.P. Has $5.28 Million Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
Alliancebernstein L.P. lifted its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 149.4% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 212,804 shares of the company’s stock after purchasing an additional 127,494 shares during the quarter. Alliancebernstein L.P.’s holdings in […] - 2025-04-13 05:44:47
KLP Kapitalforvaltning AS Makes New Investment in Beam Therapeutics Inc. (NASDAQ:BEAM)
KLP Kapitalforvaltning AS purchased a new stake in shares of Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 13,400 shares of the company’s stock, valued at approximately $332,000. Other hedge funds and other institutional investors have […] - 2025-04-06 07:35:04
Mitsubishi UFJ Asset Management Co. Ltd. Has $244,000 Stake in Beam Therapeutics Inc. (NASDAQ:BEAM)
Mitsubishi UFJ Asset Management Co. Ltd. lowered its position in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 9,613 shares of the company’s stock after selling 995 shares during the period. Mitsubishi UFJ Asset Management Co. […] - 2025-04-04 05:12:58
Stocks Tumble on Weaker US Consumer Spending and Sticky Price Pressures
The S&P 500 Index ($SPX ) (SPY ) today is down -1.47%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.89%. June E-mini S&P futures (ESM25 ) are down -1.43%, and June E-mini Nasdaq futures... - 2025-03-28 18:31:32
AlphaQuest LLC Reduces Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)
AlphaQuest LLC trimmed its stake in Beam Therapeutics Inc. (NASDAQ:BEAM – Free Report) by 92.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,610 shares of the company’s stock after selling 33,583 shares during the period. AlphaQuest LLC’s holdings in Beam Therapeutics […] - 2025-03-20 06:13:05
Beam Therapeutics (NASDAQ:BEAM) Earns Overweight Rating from Cantor Fitzgerald
Beam Therapeutics (NASDAQ:BEAM – Get Free Report)‘s stock had its “overweight” rating reaffirmed by research analysts at Cantor Fitzgerald in a research report issued on Wednesday,Benzinga reports. BEAM has been the subject of several other research reports. Guggenheim reaffirmed a “buy” rating and issued a $78.00 price objective on shares of Beam Therapeutics in a […] - 2025-03-14 04:44:57

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc BEAM holdings

DateNumber of BEAM Shares HeldBase Market Value of BEAM SharesLocal Market Value of BEAM SharesChange in BEAM Shares HeldChange in BEAM Base ValueCurrent Price per BEAM Share HeldPrevious Price per BEAM Share Held
2025-09-26 (Friday)10,081USD 231,561USD 231,561
2025-09-25 (Thursday)10,081USD 232,770BEAM holding decreased by -5041USD 232,7700USD -5,041 USD 23.09 USD 23.59
2025-09-24 (Wednesday)10,081USD 237,811USD 237,811
2025-09-17 (Wednesday)10,017USD 224,882BEAM holding decreased by -4607USD 224,8820USD -4,607 USD 22.45 USD 22.91
2025-09-16 (Tuesday)10,017USD 229,489USD 229,489
2025-09-12 (Friday)9,953USD 205,032USD 205,032
2025-09-11 (Thursday)9,953BEAM holding increased by 128USD 214,487BEAM holding increased by 18576USD 214,487128USD 18,576 USD 21.55 USD 19.9401
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of BEAM by Blackrock for IE00B3VWM098

Show aggregate share trades of BEAM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-09-11BUY128 21.550* 22.01
2025-08-21SELL-32 16.010* 22.05 Profit of 706 on sale
2025-07-31BUY96 19.710* 22.10
2025-06-30SELL-64 17.010* 22.34 Profit of 1,430 on sale
2025-06-25SELL-32 16.760* 22.46 Profit of 719 on sale
2025-06-20SELL-64 16.760* 22.58 Profit of 1,445 on sale
2025-05-23BUY32 16.830* 23.49
2025-05-19SELL-32 17.655* 23.69 Profit of 758 on sale
2025-05-15SELL-96 17.250* 23.80 Profit of 2,285 on sale
2025-05-12SELL-32 18.240* 23.96 Profit of 767 on sale
2025-05-09SELL-32 17.410* 24.02 Profit of 769 on sale
2025-04-30SELL-32 19.930* 24.39 Profit of 780 on sale
2025-04-24SELL-64 20.170* 24.57 Profit of 1,573 on sale
2025-04-17SELL-32 17.000* 24.91 Profit of 797 on sale
2025-04-15SELL-96 17.280* 25.08 Profit of 2,408 on sale
2025-04-14SELL-96 17.000* 25.17 Profit of 2,416 on sale
2025-04-09SELL-128 16.370* 25.49 Profit of 3,263 on sale
2025-04-07SELL-224 15.300* 25.74 Profit of 5,765 on sale
2025-04-04SELL-320 15.270* 25.86 Profit of 8,274 on sale
2025-03-31BUY32 19.530* 26.12
2025-03-19SELL-64 23.640* 26.46 Profit of 1,694 on sale
2025-03-14SELL-192 24.230* 26.57 Profit of 5,102 on sale
2025-03-13SELL-64 25.060* 26.60 Profit of 1,702 on sale
2025-03-12SELL-1,088 27.420* 26.58 Profit of 28,923 on sale
2025-03-07SELL-64 28.480* 26.57 Profit of 1,701 on sale
2025-03-06SELL-96 27.250* 26.56 Profit of 2,550 on sale
2025-03-03SELL-32 25.100* 26.59 Profit of 851 on sale
2025-02-28SELL-192 26.340* 26.60 Profit of 5,107 on sale
2025-02-26SELL-32 27.890* 26.57 Profit of 850 on sale
2025-02-25SELL-96 29.840* 26.51 Profit of 2,545 on sale
2025-02-18BUY160 33.490* 25.81
2025-02-13BUY32 28.610* 25.50
2025-02-12BUY32 28.570* 25.43
2025-02-11BUY96 26.850* 25.40
2025-02-06BUY288 27.650* 25.28
2025-01-27BUY32 25.910* 25.09
2024-12-30BUY160 25.270* 25.03
2024-12-06BUY128 26.710* 24.72
2024-12-05BUY32 25.320* 24.70
2024-12-04BUY160 26.020* 24.65
2024-11-29BUY160 27.370* 24.35
2024-11-27BUY128 27.200* 24.10
2024-11-26BUY32 25.840* 24.02
2024-11-21BUY160 23.580* 23.85
2024-11-20BUY96 24.490* 23.81
2024-11-18BUY384 24.120* 23.70
2024-11-12BUY256 27.940* 23.42
2024-11-08BUY160 27.060* 23.16
2024-11-07BUY480 26.100* 22.93
2024-11-06BUY64 26.620* 22.63
2024-10-31BUY32 21.910* 22.30
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of BEAM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19902,6942,1901,217,28174.2%
2025-09-181,122,5532,1891,640,60768.4%
2025-09-171,023,7333,8001,519,53867.4%
2025-09-16874,3396,1271,309,36766.8%
2025-09-15538,772247846,75063.6%
2025-09-12707,8961,4611,138,94962.2%
2025-09-11875,8556,8201,546,79656.6%
2025-09-10584,7521,614920,94163.5%
2025-09-09518,7102,293845,13961.4%
2025-09-08801,5075311,193,47367.2%
2025-09-051,238,7021,6372,031,03661.0%
2025-09-04900,7268001,465,11161.5%
2025-09-032,412,9004,9744,102,04458.8%
2025-09-02378,279147620,57161.0%
2025-08-29467,30111760,35261.5%
2025-08-28548,9910842,79965.1%
2025-08-27408,469600672,07960.8%
2025-08-26492,3140682,16272.2%
2025-08-25519,376200776,15266.9%
2025-08-22441,803100965,14445.8%
2025-08-21627,68501,043,50960.2%
2025-08-20809,0612641,230,70965.7%
2025-08-19782,9021,1001,398,03356.0%
2025-08-18556,5491,3941,234,38545.1%
2025-08-15461,18460779,89759.1%
2025-08-14848,848361,578,76053.8%
2025-08-13638,94001,311,07048.7%
2025-08-12670,9271,4551,113,55160.3%
2025-08-11466,6511,300802,25658.2%
2025-08-08323,809557746,12343.4%
2025-08-07372,64679763,80548.8%
2025-08-06669,329411,014,66366.0%
2025-08-051,074,6661,3471,597,18267.3%
2025-08-04529,057294703,68175.2%
2025-08-01702,8841,6191,140,50361.6%
2025-07-31484,476234942,89051.4%
2025-07-30702,8972,3681,181,92459.5%
2025-07-29557,7493,448868,26564.2%
2025-07-28508,5282,673759,68366.9%
2025-07-25416,9911,572695,00660.0%
2025-07-24538,292931,234,25143.6%
2025-07-23503,90010,0951,044,03548.3%
2025-07-22419,910309811,77851.7%
2025-07-21666,9243,4081,264,47252.7%
2025-07-18379,990371881,11543.1%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.